RELA and Alzheimer disease: As shown in Fig. 5b, the topical application of JO on AD-like lesion rarely affected DNCB-mediated phosphorylation of p65 subunit at Ser536, which is located at trans-activation domain of p65 and well known for the NFκB activity [46, 47].